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Abstract
Background: Social prescribing is targeted at isolated and lonely patients. Practitioners and patients jointly develop
bespoke well-being plans to promote social integration and or social reactivation. Our aim was to investigate: whether
a social prescribing service could be implemented in a general practice (GP) setting and to evaluate its effect
on well-being and primary care resource use.
Methods: We used a mixed method evaluation approach using patient surveys with matched control groups
and a qualitative interview study. The study was conducted in a mixed socio-economic, multi-ethnic, inner city London
borough with socially isolated patients who frequently visited their GP. The intervention was implemented by ‘social
prescribing coordinators’. Outcomes of interest were psychological and social well-being and health care resource use.
Results: At 8 months follow-up there were no differences between patients referred to social prescribing and the
controls for general health, depression, anxiety and ‘positive and active engagement in life’. Social prescribing patients
had high GP consultation rates, which fell in the year following referral. The qualitative study indicated that most patients
had a positive experience with social prescribing but the service was not utilised to its full extent.
Conclusion: Changes in general health and well-being following referral were very limited and comprehensive
implementation was difficult to optimise. Although GP consultation rates fell, these may have reflected regression
to the mean rather than changes related to the intervention. Whether social prescribing can contribute to the
health of a nation for social and psychological wellbeing is still to be determined.
Keywords: Mixed methods, Evaluation, Social prescribing, Primary care
Background
Since the 1990s there has been a shift from the concept
of the biomedical health care model to the biopsychoso-
cial model of understanding health states and disease,
particularly for non-communicable chronic illnesses
such as back and neck pain [1]. In the last few years
there has been an emergence of interventions focusing
on the social component of care, such as social prescrib-
ing, art on prescription, exercise/physical activity on
prescription, walking groups and the introduction of
health trainers, with some evidence for behaviour change
[2–4]. These aim to help people manage their chronic
condition, prevent more serious health problems devel-
oping, and contribute to addressing health inequalities
by building social support networks.
The emergence of these interventions are in part due
to the aging population, increases in chronic conditions,
levels of social isolation and the growing burden of pro-
viding health care [5]. There is scope for providing new
and innovative interventions to promote the self-
management of chronic conditions potentially reducing
the need for physician led care. Despite the increase in
socially oriented health services, their effectiveness
remains uncertain: a review of 12 evaluations of UK
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social prescribing services showed that the rigour of
evaluations was limited and that none of the evaluations
had an adequate control group [6]. However some of the
service evaluation reports indicated some beneficial
changes in anxiety, depression, wellbeing, social isolation
and general practice attendance [7, 8].
There is no standard definition of social prescribing
but we describe it as: a non-medical referral, or linking
service, to help people identify their social needs and
develop ‘well-being’ action plans to promote, establish or
re-establish integration and support in their communi-
ties, with the aim of improving personal wellbeing.
In January 2014 the London Borough of City and Hack-
ney Clinical Commissioning Group (CCG) commissioned
a pilot project for a social prescribing service in three
areas comprising 22 primary care general practices. The
aim of the social prescribing service was to improve
patient well-being and increase personal self-efficacy
shown by a reduction in primary health care resource use.
The aim of the evaluation was twofold: i) to assess the
effect of the service on mental wellbeing and primary
health care resource use and ii) to assess the whether
the service could be implemented as intended.
The aim of this paper is to present data about the
effect of the service on the people referred and the
implementation of the service from a patient
perspective.
Methods
We used a mixed methods approach to evaluate the
service and test its effect on patients. For the service
evaluation we monitored activity in the service and we
interviewed patients to explore their views and experi-
ences of the service. To compare the effect on patient
reported health related outcomes we used a matched
controlled group to assess ‘non-exposed’ patients using a
postal questionnaire survey. For health care resource use
we searched electronic patient records and compared
those referred into social prescribing with a propensity
matched control group. The evaluation period was from
the service inception, Feb 1st 2014 to January 31st 2016.
The setting
The social prescribing service was piloted in the London
Borough of City and Hackney which is characterised by
an extreme range of socio-economic deprivation and
affluence and a considerable ethnic mix [9].
Three areas in the borough were included and were
assigned a social prescribing coordinator. The coordinators
were trained in social work and employed by a managing
third sector (not-for-profit) organisation commissioned to
implement the service. Three social prescribing coordina-
tors were appointed and worked in the 22 GP surgeries
enrolled.
Population
The population of interest were patients in general
practices who were frequent attenders and, or socially
isolated. People were not referred if they were in acute
crisis, at risk to self and/or others, had uncontrolled
addictions or uncontrolled mental health problems.
The social prescribing service
Patients were referred to a Social prescribing coordin-
ator. At the first meeting with the coordinator, the
patients discussed their personal circumstances and if
possible a mutually determined well-being action plan
was devised. The action plan contained goals for im-
proving patient wellbeing, in some cases this involved
referring patients to community organisations and
services. If necessary a volunteer was assigned to help
the patient achieve their goals. Volunteers were trained
Fig. 1 Description of barriers and facilitators to social engagement via the social prescribing service
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by the Social prescribing coordinators to assist in the de-
livery of the service and provide additional support to
clients. Patients could receive up to six sessions with the
social prescribing coordinator and as many contacts with
the volunteer as required.
Evaluation of effect of service on patients
a) Patient reported mental wellbeing
All patients referred to the social prescribing service
were sent a questionnaire by the independent
evaluation research team, prior to their first
appointment (where possible) and after eight
months. Patients were asked basic demographic
information about: age, sex, employment status,
education status, English language fluency, and living
alone or not. We collected data about general health
[10], wellbeing [11], anxiety and depression [12],
number of regular activities, accident and emergency
visits in last 3 months and positive and active
engagement in life [13]. The eight month follow-up
questionnaire also included questions about
satisfaction.
The control group consisted of a randomly selected
group of patients from neighbouring areas not
involved in the social prescribing scheme. People
were selected and matched by: age, older than 23
and younger than 85 years, GP attendance (last
3 months) and at least one of the following:
depression, anxiety, type 2 diabetes. Exclusion
criteria were: palliative care and housebound.
A sample of 3000 people were invited to take part in
a questionnaire survey about their health and
wellbeing with a view to getting around a 10%
response rate (based on prior surveying experience
in this population) to match the number of patients
expected to be referred into the social prescribing
service (300 over a 12 month period). These
participants were given the same questionnaire as
those referred into social prescribing and were
followed up at 8 months.
Analysis: We compared questionnaire mean scores
from the social prescribing patients and the controls
at baseline and at 8 months.
b) Primary health care resource use
Primary health care use data were collected
electronically and anonymously from patient health
care records. All GP referrals into the social
prescribing scheme were flagged by a unique
identification code. Matched controls were identified
from the referring practice populations. For every
patient referred, up to 20 matched controls with
similar demographic characteristics were identified.
Demographics used to match patients were: age, sex,
ethnic group, general practice (by Index of Multiple
Deprivation) and the presence of co-morbidities
(cardiovascular disease, respiratory and mental
health conditions). Using anonymised consultation
and prescribing data we compared annual GP
consultations and number of medications prescribed
(antidepressants, antipsychotics, anxiolytics,
nonsteroidal anti-inflammatory drugs and opioid
analgesics) for the year prior and the year following
the date of referral between social prescribing
attenders and their matched controls.
Analysis: We used non-parametric statistics and
linear regression to compare the social prescribing
group with the controls.
Evaluation of the service from a patient perspective
In this report we present information about the patients
and their perspectives of the service.
a) Activity
The commissioned service provider was requested
to keep monthly records of the number of people
referred into the service (by GP and practice), the
sex, age, number and type of contacts with the social
prescriber and volunteers and places that people
were referred to in the community setting.
b) Interviews with patients
We used a phenomenological approach to capture
patient experience, beliefs and opinions at one point
in time. We tried to access patients who had fully
engaged with the social prescribing service (2 or
more contacts), partially engaged (1 contact) and
those who did not engage at all (0 contacts). We
randomly sampled 100 patients from each category
to approach for interview. Subsequently we aimed to
interview 20 patients by using purposive sampling to
maximise the variety and range of patients
interviewed in terms of sex, age and ethnicity.
We conducted semi-structured interviews covering:
lifestyle (to establish their levels of social isolation),
the way they were referred into the service, what
they knew about the service, their level of
engagement in, and experience of the service and
recommendations for the future. Four of the authors
(DC, MB, CF, RS) conducted the interviews by
telephone and face to face where possible. Copious
notes were taken, interviews were not transcribed
verbatim. Signed consent was obtained from each
participant.
Analysis: We familiarised ourselves with the content
of the interviews and organised the data by
responses to questions (the topic areas). By
consensus we agreed on emerging themes and
sub-themes. Data was aligned with each theme and
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sub-theme and any dissonant data or data left over
was considered separately.
Results
Quantitative evaluation
Twenty-two general practices referred patients into the so-
cial prescribing service (range: patients per practice 1–108).
The mean number of patients referred per month was 45
(range 25–59). A total of eighty-two community organisa-
tions were used in the delivery of the service, although most
participants were sent to 10% of these. The community or-
ganisations were diverse and reflected the different interests
of people, for example exercise classes, cookery lunch clubs,
library visits, religious groups and ping pong. Nineteen
volunteers were trained, 10 were used.
Of the patients referred (Table 1), 17% had more than
one contact with the service, 14% had no contact at all
and the remainder had one contact. Patient reasons for
non-engagement following referral included: declined to
participate, reason unknown, uncontactable, other com-
mitments, ill health, moved away, unclear of reason for
referral.
Patient reported outcomes
The questionnaire response rate for the social prescrib-
ing group at baseline was 39% (184/475) and at 8 months
38% (69/181). For the controls the response rate at base-
line was 10% (302/3000) and at 8 months 42% (127/302)
(Table 2).
The control and intervention groups differed in three
ways, the control group were more likely to be living
with others, in paid work and were in full time educa-
tion for longer.
Baseline data and change at 8 months
There was no statistically significant difference in any
outcome between baseline and 8 months (Tables 3 and 4).
Both the social prescribing group and the control
group showed positive changes in anxiety (though not
depression) over the 8 months period. However, the
control sample was in better mental health at baseline
(Table 3).
The change in patient reported outcome scores for
general health, depression, anxiety, wellbeing and active
engagement in life were analysed using a linear regres-
sion model (Table 4). This type of analysis predicts what
treatment effect our social prescribing service had on
people in the study. Both the non-adjusted and adjusted
models (taking into account the different demographic
profiles) showed that the social prescribing service did
not have any statistically significant effects on patients’
general and mental health, wellbeing and active living
changes. However there was a reduction in the number
of activities between baseline and follow-up indicating a
negative effect.
Health care resource use
Across the participating general practices, the study
identified 381 patients referral to social prescribing. For
these 381 participants, 7540 controls, matched by age, sex,
ethnicity and co-morbidities were identified (Table 5).
The annual GP consultation rate in those referred to
social prescribing was significantly higher than in con-
trols both before and in the year following the date of
referral to social prescribing. The GP consultation rate
within controls was higher after their matched compara-
tor referral date compared to before, whilst the GP con-
sultation rate for those referred into social prescribing
Table 1 Engagement in service (Feb 2014 – Mar 2015)
Consultations between patient and social prescribing coordinator/volunteer Number (%) of people referred into social prescribing (n = 585)
No contact 81 (14)
Single consultation 405 (69)
Between 2 and 4 consultations 79 (14)
Between 5 and 6 consultations 20 (3)
Table 2 Demographic profile of participant and control patients
responding to the survey at baseline
Characteristics Control Group
n = 302
Intervention Group
n = 184
P-value
Age (Median (IQR)) 58 (20) 56 (22) 0.376a
Gender (n (%))
Female 164 (54) 103 (59)
Male 137 (46) 72 (41) 0.354b
Ethnicity (n (%))
White 170 (58) 88 (49)
Non-White 123 (42) 90 (51) 0.070b
Living arrangement (n (%))
Alone 106 (37) 101 (60)
With others 180 (63) 66 (40) < 0.001b
Work status (n (%))
Not paid 153 (53) 162 (91)
Paid 136 (47) 17 (9) < 0.001b
Education (n (%))
Up to 16 years 111 (39) 100 (58)
17 years or above 175 (61) 72 (42) < 0.001b
aMedian test, bChi square test
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was lower after the referral date compared to before
(Table 5).
The analysis showed that the number of medications
prescribed to cases was significantly higher for those re-
ferred into social prescribing both before and after the
intervention. The number of medications prescribed in-
creased slightly in the controls after the referral date but
the number of medications prescribed in those referred
to social prescribing remained stable (Table 5).
Qualitative evaluation
Satisfaction with the service
Most clients (55% 35/60)) were satisfied with the social
prescribing service they received at 8 months, 70% (42/60)
would have liked more information about the service and
62% (39/63) would recommend the service to others.
Patient interviews
Of the randomly selected 100 clients from the three differ-
ent groups: full, partial and non-attenders, to be inter-
viewed: fifteen people responded to the letters and
consented to be interviewed. Of these, five people were
available for interview. The remainder were too busy,
non-contactable or did not want to participate. Examples
for non-participation included: moved, unwell, in hospital.
As our sampling method only generated five inter-
views, we asked the managing organisation to contact an
additional participants. This resulted in the completion
of 15 additional interviews which were well balanced be-
tween sex, ethnicity and age (63% were aged 50 years or
over) but all had engaged in the service. Of those inter-
viewed two people had been invited to social prescribing
but did not attend, six attended one or two sessions the
remainder (7) three or more.
Two strong themes emerged from the data about: I)
Processes and procedures and II) Engagement and
outcomes. No dissonant data was found.
Theme I. Processes and procedures
Sub themes included i) patients being overwhelmed by
their care provision and ii) appropriateness and timing
of the referral. This included GP ‘parentalism’ and where
patient’s thresholds of needs were too high (or low).
“My GP knows me so well he probably just referred me
because he thought it would be good for me”
(Pt partially engaged)
“I had too many other things going on [family crises]”
(Pt not engaged)
Table 3 Comparison of outcome variables between baseline and 8 month follow-up
Outcomes Control Group Intervention Group
Baseline Follow-up Baseline Follow-up
n Mean (S.D.) n Mean (S.D.) n Mean (S.D.) n Mean (S.D.)
General health scorea 296 3.3 (1.00) 127 3.3 (1.02) 184 2.8 (1.00) 65 2.7 (0.95)
HADS Anxiety score (range 0–21)b 287 8.1 (5.47) 124 7.6 (5.43) 175 11.3 (5.02) 63 11.2 (5.02)
HADS Depression score (scale 0–21)b 295 6.7 (5.22) 124 5.9 (5.22) 174 9.9 (5.08) 64 10.1 (5.06)
HADS score (scale 0–41)b 286 14.8 (9.88) 122 13.4 (9.99) 169 21.1 (9.57) 63 21.3 (9.36)
Wellbeing (past week) (range 0–6) 300 3.6 (1.52) 126 3.9 (1.44) 184 2.8 (1.47) 65 2.8 (1.44)
Active engagement in life score (scale 0–20)c 293 13.7 (3.92) 121 14.1 (3.89) 179 13.5 (3.88) 62 13.5 (3.83)
Number of regular activities (range 0–6) 302 2.8 (2.24) 126 2.9 (2.27) 184 1.9 (1.66) 43 1.3 (1.31)
A&E visits in past 3 months 289 0.3 (0.79) 121 0.5 (1.15) 47 0.3 (0.68)
aGeneral health scores 1 = very bad; 5 = very good. bAnxiety and depression Scores between 0 and 7 in both anxiety and depression scales are considered normal,
with 8–10 borderline and 11 or over indicating clinical ‘caseness’. cHeiQ Scale is between 5 and 20: 5 = poorly integrated; 20 = well integrated
Table 4 Effect of social prescribing on general and mental
health, wellbeing and active living
Linear regression model on outcome differences (between baseline and
follow-up) against treatment group
Outcomes Non-adjusted Adjusteda
Coef. (95% Conf.
Interval)
Coef. (95% Conf.
Interval)
General health score −0.029 (−0.312,
0.253)
0.127 (−0.221,
0.475)
HADS Anxiety score (range 0–21) −0.542 (−1.837,
0.752)
−0.119 (−0.847,
1.609)
HADS Depression score
(range 0–21)
0.679 (−0.566,
1.924)
0.857 (−0.737,
2.451)
HADS score (range 0–41) 0.232 (−2.113,
2.577)
0.906 (−2.144,
3.957)
Wellbeing (past week)
(range 0–6)
−0.089 (−0.569,
0.391)
−0.013 (−0.623,
0.596)
Active engagement in life score
(range 0–20)
0.023 (−0.957,
1.004)
−0.073 (−1.278,
1.131)
Number of regular activitiesb −0.856 (−1.518,
−0.194)
−0.897 (−1.729,
−0.065)
aAdjusted with control variables, including age, sex, ethnicity, work status and
living arrangement
bp = 0.012 for non-adjusted model and p = 0.035 for adjusted model
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Some interviewees were not sure what social prescribing
was and who the service delivery organisation was,
despite having been referred.
“I have no idea who or what you are talking about,
but sounds a good idea, I don’t know why I was
referred……..” (Pt not engaged)
Names used for social prescribing coordinators included:
wellbeing coordinators, managing organisation support,
social prescribers, counsellors, navigators, link workers,
supporters, members of the general practice team.
The coordinators established themselves as part of the
general practice services, in part because the one to one
consultations that happened in the general practice
surgeries. As a consequence users did not recognise the
term social prescribing but only remembered their
coordinators. This was mainly because the people we
interviewed saw so many different health care profes-
sionals they had lost track of who they were seeing.
“I don’t know who she was [in terms of health care
professional]……I can’t remember her name…..errr but
she was very nice” (Pt engaged)
“The problem is there are lots of services and lots of
names, I get confused” (Pt partially engaged)
Theme II. Engagement and outcome
The sub themes focused on the coordinator and patient
relationship and understanding of the service. Where
contact with wellbeing coordinators was established, this
left a lasting impression either because expectations
were surpassed or because expectations were unmet
(often illustrating a lack of understanding about the ser-
vice). The role of coordinators seemed to work best
when they addressed some of the entrenched health and
well-being issues patients had, illustrating that the role
of a social prescribing coordinator was more than
logistical coordination but important for facilitating the
self-management of life skills and thus the health condi-
tions. Wellbeing co-ordinators dealt with a range of
needs from straightforward sign-posting to, what was in
essence, a more intensive coaching-style intervention.
Some of the most positive outcomes reported by
patients resulted from experiencing sessions which
allowed them the time to explore their situation more
fully and work collaboratively to set realistic goals for
the future.
“It’s done me a world of good, taken me out of the
house, given me a routine and given me a sense of
purpose and …hope. It’s given me back my confidence”
(Pt engaged)
“It [social prescribing] gave me the motivation to think
I might be ready to go back to work” (Pt engaged)
“It [a voluntary organisation return to work scheme]
allowed me to keep my hand in, so when I was ready
to go back to work [this meant] I wouldn’t have not
been working since 2012………….I’ve [now] got
references and skills that are current” (Pt engaged)
Overall interpretive analysis
Figure 1, illustrates the process of social prescribing in
City and Hackney. It shows three phases in the process,
first with the GP, then the social prescriber and finally
the patient’s/client’s entry into the voluntary sector or
the community. The ‘successful’ clients moved through
each stage and emerged after exposure to all three stages
as ready to move on or requiring further support. The
reasons for not going through each stage are shown in
the orange boxes and include: lack of understanding,
Table 5 Comparison of GP consultation and medication use before and after referral date between those referred to social
prescribing and controls
Social prescribing N control Median (IQR) N referred into
social prescribing
Median (IQR) Two-sample Wilcoxon rank-sum
(Mann-Whitney) test for
non-parametric data
Annual GP consultation rate before referral 7540 2.9 (0.6–5.8) 377 8.3 (5.8–12.1) p < 0.001
Annual GP consultation rate after referral 7540 3.3 (0–6.4) 377 7.3 (4.7–10.7) p < 0.001
Two-sample Wilcoxon rank-sum (Mann-Whitney)
test for non-parametric data
p = 0.014 p = 0.001
No. of medications 6 months before referral 7540 0 (0–1) 377 2 (1–3) p < 0.001
No. of medications 6 months after referral 7540 0 (0–1) 377 2 (1–3) p < 0.001
Two-sample Wilcoxon rank-sum (Mann-Whitney)
test for non-parametric data
p = 0.022 p = 0.156
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lack of perceived need, overwhelmed by other health
needs, logistical problems getting out and about.
Discussion
All the participating general practices referred patients
into the service. Of the patients referred 69% received at
least one contact, either by telephone or face to face,
only 17% received two or more contacts. This limited
exposure to the service may partly explain the lack of
impact on outcomes.
Those referred into social prescribing seemed to fit the
referral criteria. They consulted more frequently and
were prescribed more medication than the controls, and
were significantly more likely to be living alone and
unemployed. They were more anxious, depressed, they
rated their general health and wellbeing worse than con-
trols but interestingly their level of positive and active
engagement in life were about the same.
There were no significant changes in general health,
wellbeing, anxiety, depression, levels of positive and
active engagement in life over time in either the social
prescribing or the control groups. A finding which is dif-
ficult to explain is the reduction in number of activities
in the intervention arm. In contrast the qualitative study
showed there were strong and powerful narratives about
the impact social prescribing had on some patients.
The consultation data needs interpreting with care be-
cause: i) there were a large number of controls, so a
small rise in the median value for consultation rate over
time for controls (2.9 to 3.3) was statistically significant
and ii) the statistically significant drop in median GP
consultation rate from 8.3 to 7.3 was in part, because
GPs referred patients because they had higher than
average rates of attendance (alongside perceived social
isolation) so the identified changes may represent regres-
sion to the mean, rather than a change related to the
efficacy of the intervention. Without evidence from a
randomised controlled trial it would be premature to
conclude that social prescribing reduced GP consult-
ation rates.
Strengths and limitations of this evaluation
The major strength of this evaluation is that it had two
control groups: one for the comparison of patient
reported outcomes by questionnaire, and the other for
primary health care resource use using electronic patient
records. This is the most comprehensive control group
comparison to date.
A weakness however is the response rates, as with any
evaluation of this nature in communities where English
fluency and literacy is varied, it is difficult to collect data
via postal questionnaires. The response rate at 8 months
from those referred into social prescribing was only 14%
(69/475). Furthermore, we do not have data about which
clients actually went to which activities, organised by
which voluntary organisations and how many times they
went. The impact of the social prescribing service in the
community organisations is not discernible but we do
know that a large number of diverse organisations, activ-
ities and events were recommended.
Findings in relation to other studies
The findings for social prescribing type of initiatives are
comparable to other trials and evaluations of self-
management programmes [14, 15] in that the evidence
for effectiveness is inconsistent, small to moderate, at
best, and only on some outcomes [6, 7, 16]. Health care
resource use and subsequent evidence of reduction, and
hence cost, remain powerful indicators for commis-
sioners to fund these sorts of interventions. Two other
studies reported promising data about health care re-
source use reduction as did we but whilst this data
shows promise as with the other two studies the results
have to be viewed with caution. Our qualitative study
elicited strong positive narratives similar to case studies
reported in other evaluations [17–19] but the quantita-
tive data did not support or reflect the strength of these
narratives throughout the whole referred group.
Due to the complex nature of these patients, long term
multiple health states and social conditions, resolution
perhaps is not the end goal but better quality of life and
/or mental wellbeing. Given the discrepancy between the
qualitative and quantitative literature on social prescrib-
ing, it could be that the standard health outcome mea-
sures do not capture the ‘non-health’ related outcomes
that reflect patient priorities and their perspective of their
own health and wellbeing [20]. Another point worth mak-
ing, is that interventions of this nature that require the
person’s active participation, engagement and commit-
ment might be ‘exposure’ or ‘dose’ dependent, at present
little is known about levels of patient exposure and inter-
vention fidelity that might affect outcome [21–24].
Implications for practice and research
Fidelity, making sure the service is delivered as it should
be can be difficult, the problems encountered in the im-
plementation of this social prescribing service have been
experienced by others and recommendations to optimise
service reported elsewhere [22]. From our evaluation
experience we would emphasise the following:
1. The social prescribing has a patient recognisable
identity
2. Coordinators are located in the GP surgery
3. Co-ordinators have non-clinical training, strong
interpersonal and motivational skills.
4. Assessment of outcomes are those important to
patients
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Further research is needed from the GPs point of view.
We propose that being able to share the needs of highly
dependent patients with a social prescribing service is
valuable in itself. Further work may need to be done to
establish the right measurement tools and the appropri-
ate timescale for data collection and a cluster rando-
mised controlled trial with a full health economic
analysis might provide more robust evidence for policy
makers and commissioners thinking of this type of
service provision. More work is also needed to ensure
optimal delivery of social interventions to understand
their potential effects. The concept of delivering social
interventions on the theoretical assumption that build-
ing social self-efficacy can relieve congestion in the GP
surgery may be misguided. Perhaps a better conception
is to give value to self-efficacy and social capital and
consider other mechanisms to reduce attendance at GP
surgery.
Conclusion
Changes in general health and well-being following re-
ferral were very limited. Comprehensive implementation
was difficult to optimise and possibly explains the poor
quantitative outcomes in comparison with the positive
narratives reported by those fully engaging with the ser-
vice. Although GP consultation rates fell, these may have
reflected regression to the mean rather than changes
related to the intervention. Social prescribing is still in
relative infancy and the health benefit of social and psy-
chological well-being as part of the overall health of a
nation strategy is still to be determined.
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